- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/31 - Mercury compounds containing nitrogen
Patent holdings for IPC class A61K 31/31
Total number of patents in this class: 39
10-year publication summary
|
3
|
0
|
4
|
1
|
1
|
1
|
3
|
4
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Vanda Pharmaceuticals, Inc. | 382 |
5 |
| Suven Life Sciences Limited | 136 |
2 |
| Vaccinex, Inc. | 119 |
2 |
| F. Hoffmann-La Roche AG | 7837 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6600 |
1 |
| Board of Regents, The University of Texas System | 6050 |
1 |
| The Johns Hopkins University | 5825 |
1 |
| Arteriocyte Medical Systems, Inc. | 30 |
1 |
| Bausch & Lomb Incorporated | 1082 |
1 |
| Biophore India Pharmaceuticals Pvt. Ltd. | 90 |
1 |
| BioTheryX, Inc. | 96 |
1 |
| Centro di Riferimento Oncologico | 11 |
1 |
| Hospital District of Helsinki and Uusimaa | 2 |
1 |
| Intercontinental Great Brands LLC | 1583 |
1 |
| Kwon, Youngja | 1 |
1 |
| Lupin Limited | 430 |
1 |
| Niiki Pharma Inc. | 16 |
1 |
| Norton Healthcare Limited | 90 |
1 |
| Oscotec Inc. | 25 |
1 |
| Politecnico di Torino | 384 |
1 |
| Other owners | 13 |